These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

859 related items for PubMed ID: 25633654

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F, Cadron I, Fuso L, Berteloot P, de Jonge E, Jacomen G, Van Robaeys J, Neven P, Moerman P, Vergote I.
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Early-stage Uterine Pure and Mixed Clear Cell Carcinoma: Outcomes and Recurrence With and Without Adjuvant Therapy.
    Chang-Halpenny CN, Natarajan S, Hwang-Graziano JM.
    Am J Clin Oncol; 2018 Apr; 41(4):371-378. PubMed ID: 26950465
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of adjuvant treatment on outcome in high-risk early-stage endometrial cancer: a retrospective three-center study.
    Helpman L, Perri T, Lavee N, Hag-Yahia N, Chariski HA, Kalfon S, Derazne E, Beiner ME, Kadan Y, Fishman A, Korach J, Covens A, Gien L.
    Int J Gynecol Cancer; 2019 Jan; 29(1):133-139. PubMed ID: 30640695
    [Abstract] [Full Text] [Related]

  • 9. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
    Bansal N, Herzog TJ, Seshan VE, Schiff PB, Burke WM, Cohen CJ, Wright JD.
    Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
    [Abstract] [Full Text] [Related]

  • 10. Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy?
    Velker V, D'Souza D, Prefontaine M, McGee J, Leung E.
    Int J Gynecol Cancer; 2016 Mar; 26(3):491-6. PubMed ID: 26825823
    [Abstract] [Full Text] [Related]

  • 11. Does the FIGO 2009 endometrial cancer staging system more accurately correlate with clinical outcome in different histologies? Revised staging, endometrial cancer, histology.
    Page BR, Pappas L, Cooke EW, Gaffney DK.
    Int J Gynecol Cancer; 2012 May; 22(4):593-8. PubMed ID: 22343970
    [Abstract] [Full Text] [Related]

  • 12. Treatment failure in endometrial carcinoma.
    Huang HJ, Tang YH, Chou HH, Yang LY, Chao A, Huang YT, Lin G, Liu FY, Chang TC, Lai CH.
    Int J Gynecol Cancer; 2014 Jun; 24(5):885-93. PubMed ID: 24819657
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma.
    Desai NB, Kollmeier MA, Makker V, Levine DA, Abu-Rustum NR, Alektiar KM.
    Gynecol Oncol; 2014 Oct; 135(1):49-53. PubMed ID: 25084509
    [Abstract] [Full Text] [Related]

  • 15. Impact of body mass index on surgical outcomes and analysis of disease recurrence for patients with endometrial cancer undergoing robotic-assisted staging.
    Menderes G, Azodi M, Clark L, Xu X, Lu L, Ratner E, Schwartz PE, Rutherford TJ, Santin AD, Silasi DA.
    Int J Gynecol Cancer; 2014 Jul; 24(6):1118-25. PubMed ID: 24927247
    [Abstract] [Full Text] [Related]

  • 16. Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas.
    Ayeni TA, Bakkum-Gamez JN, Mariani A, McGree ME, Weaver AL, Haddock MG, Keeney GL, Long HJ, Dowdy SC, Podratz KC.
    Gynecol Oncol; 2013 Jun; 129(3):478-85. PubMed ID: 23535279
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic features of surgical stage I uterine carcinosarcoma.
    Ferguson SE, Tornos C, Hummer A, Barakat RR, Soslow RA.
    Am J Surg Pathol; 2007 Nov; 31(11):1653-61. PubMed ID: 18059221
    [Abstract] [Full Text] [Related]

  • 19. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.
    Guttmann DM, Li H, Sevak P, Grover S, Jacobson G, Feldman A, Rubin S, Chu C, Bhatia S, Elshaikh MA, Lin LL.
    Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study.
    Gadducci A, Cosio S, Zola P, Sostegni B, Fuso L, Sartori E.
    Int J Gynecol Cancer; 2013 Mar; 23(3):461-8. PubMed ID: 23370604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.